4//SEC Filing
JOHNSON & JOHNSON 4
Accession 0000950170-24-027095
$JNJCIK 0001235912operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 3:42 PM ET
Size
69.2 KB
Accession
0000950170-24-027095
Insider Transaction Report
Form 4
CVRx, Inc.CVRX
JOHNSON & JOHNSON
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2024-02-16$0.16/sh+607,725$96,021→ 4,103,300 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$5.14/sh+79$406→ 4,103,430 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−118→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc)Exercise: $0.24Exp: 2025-08-06→ Common Stock (118 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−489→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2027-02-01→ Common Stock (489 underlying) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+158$37→ 4,099,733 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+300$71→ 4,102,515 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+71$17→ 4,100,276 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+23$5→ 4,100,299 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+758$180→ 4,101,142 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+489$116→ 4,101,631 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−79→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $5.14Exp: 2031-01-04→ Common Stock (79 underlying) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+118$28→ 4,100,205 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+85$20→ 4,100,384 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Sale
Common Stock
2024-02-16$25.81/sh−3,725$96,142→ 4,099,575 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+189$45→ 4,099,922 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$1.19/sh+142$168→ 4,103,099 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−189→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (189 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−23→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (23 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−142→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc)Exercise: $1.19Exp: 2028-11-28→ Common Stock (142 underlying) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+584$138→ 4,102,215 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$1.19/sh+442$524→ 4,102,957 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$3.96/sh+252$997→ 4,103,351 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise of In-Money
Warrant to Purchase Common Stock
2024-02-16−607,225→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.16→ Common Stock (607,225 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−158→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc)Exercise: $0.24Exp: 2024-11-18→ Common Stock (158 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−165→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (165 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−71→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (71 underlying) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+165$39→ 4,100,087 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−300→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2028-02-15→ Common Stock (300 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−85→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-11-09→ Common Stock (85 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−758→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2027-02-01→ Common Stock (758 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−252→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $3.96Exp: 2029-12-05→ Common Stock (252 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−584→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2028-02-15→ Common Stock (584 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−442→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $1.19Exp: 2028-11-28→ Common Stock (442 underlying)
Transactions
- Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+71$17→ 4,100,276 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−158→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc)Exercise: $0.24Exp: 2024-11-18→ Common Stock (158 underlying) - Sale
Common Stock
2024-02-16$25.81/sh−3,725$96,142→ 4,099,575 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+165$39→ 4,100,087 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+489$116→ 4,101,631 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$1.19/sh+142$168→ 4,103,099 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise of In-Money
Warrant to Purchase Common Stock
2024-02-16−607,225→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.16→ Common Stock (607,225 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−118→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc)Exercise: $0.24Exp: 2025-08-06→ Common Stock (118 underlying) - Exercise/Conversion
Common Stock
2024-02-29$1.19/sh+442$524→ 4,102,957 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−189→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (189 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−23→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (23 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−165→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (165 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−71→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-08-06→ Common Stock (71 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−758→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2027-02-01→ Common Stock (758 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−489→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2027-02-01→ Common Stock (489 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−300→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2028-02-15→ Common Stock (300 underlying) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+300$71→ 4,102,515 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−442→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $1.19Exp: 2028-11-28→ Common Stock (442 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−252→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $3.96Exp: 2029-12-05→ Common Stock (252 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−79→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $5.14Exp: 2031-01-04→ Common Stock (79 underlying) - Exercise of In-Money
Common Stock
2024-02-16$0.16/sh+607,725$96,021→ 4,103,300 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+158$37→ 4,099,733 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+189$45→ 4,099,922 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+118$28→ 4,100,205 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+23$5→ 4,100,299 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+584$138→ 4,102,215 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$3.96/sh+252$997→ 4,103,351 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+85$20→ 4,100,384 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$0.24/sh+758$180→ 4,101,142 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Common Stock
2024-02-29$5.14/sh+79$406→ 4,103,430 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−85→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2025-11-09→ Common Stock (85 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−142→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc)Exercise: $1.19Exp: 2028-11-28→ Common Stock (142 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−584→ 0 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)Exercise: $0.24Exp: 2028-02-15→ Common Stock (584 underlying)
Footnotes (9)
- [F1]The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson.
- [F2]On February 16, 2024, JJDC exercised the Warrant to purchase 607,725 shares of Common Stock and paid the exercise price (adjusted per the net exercise terms of the Warrant) on a cashless basis, resulting in the withholding of 3,725 of the Warrant shares to pay the exercise price and issuance to JJDC of the remaining 604,000 shares.
- [F3]The Warrant became exercisable for Common Stock upon the closing of the Issuer's initial public offering and was to expire on the earlier of (i) an acquisition or asset transfer involving the Issuer or (ii) 180 days after receipt of the data from the post-market stage of the Issuer's BeAT-HF pivotal trial.
- [F4]The Warrant was transferred to JJDC from Biosense Webster, Inc., also a wholly-owned subsidiary of Johnson & Johnson, on February 14, 2024.
- [F5]Fully vested.
- [F6]174 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.
- [F7]316 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.
- [F8]506 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.
- [F9]1,185 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.
Documents
Issuer
CVRx, Inc.
CIK 0001235912
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000200406
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 3:42 PM ET
- Size
- 69.2 KB